19-4817645-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_182919.4(TICAM1):​c.733G>A​(p.Gly245Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000857 in 1,583,658 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G245G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0027 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 5 hom. )

Consequence

TICAM1
NM_182919.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.13

Publications

10 publications found
Variant links:
Genes affected
TICAM1 (HGNC:18348): (TIR domain containing adaptor molecule 1) This gene encodes an adaptor protein containing a Toll/interleukin-1 receptor (TIR) homology domain, which is an intracellular signaling domain that mediates protein-protein interactions between the Toll-like receptors (TLRs) and signal-transduction components. This protein is involved in native immunity against invading pathogens. It specifically interacts with toll-like receptor 3, but not with other TLRs, and this association mediates dsRNA induction of interferon-beta through activation of nuclear factor kappa-B, during an antiviral immune response. Mutations in this gene are associated with encephalopathy, acute, infection-induced. [provided by RefSeq, Jul 2020]
TICAM1 Gene-Disease associations (from GenCC):
  • herpes simplex encephalitis, susceptibility to, 4
    Inheritance: AR, SD, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037648976).
BP6
Variant 19-4817645-C-T is Benign according to our data. Variant chr19-4817645-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 473297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR,SD,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TICAM1NM_182919.4 linkc.733G>A p.Gly245Ser missense_variant Exon 2 of 2 ENST00000248244.6 NP_891549.1 Q8IUC6
TICAM1NM_001385678.1 linkc.691G>A p.Gly231Ser missense_variant Exon 3 of 3 NP_001372607.1
TICAM1NM_001385679.1 linkc.598G>A p.Gly200Ser missense_variant Exon 2 of 2 NP_001372608.1
TICAM1NM_001385680.1 linkc.91G>A p.Gly31Ser missense_variant Exon 3 of 3 NP_001372609.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TICAM1ENST00000248244.6 linkc.733G>A p.Gly245Ser missense_variant Exon 2 of 2 1 NM_182919.4 ENSP00000248244.4 Q8IUC6

Frequencies

GnomAD3 genomes
AF:
0.00272
AC:
414
AN:
152088
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00657
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00557
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00110
AC:
245
AN:
222390
AF XY:
0.000948
show subpopulations
Gnomad AFR exome
AF:
0.00716
Gnomad AMR exome
AF:
0.00212
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000388
Gnomad NFE exome
AF:
0.000506
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.000658
AC:
942
AN:
1431452
Hom.:
5
Cov.:
79
AF XY:
0.000639
AC XY:
453
AN XY:
709268
show subpopulations
African (AFR)
AF:
0.00684
AC:
225
AN:
32892
American (AMR)
AF:
0.00241
AC:
101
AN:
41824
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23884
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39456
South Asian (SAS)
AF:
0.0000489
AC:
4
AN:
81842
European-Finnish (FIN)
AF:
0.000319
AC:
16
AN:
50130
Middle Eastern (MID)
AF:
0.00356
AC:
19
AN:
5342
European-Non Finnish (NFE)
AF:
0.000448
AC:
491
AN:
1096960
Other (OTH)
AF:
0.00144
AC:
85
AN:
59122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
66
132
198
264
330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00273
AC:
415
AN:
152206
Hom.:
2
Cov.:
32
AF XY:
0.00281
AC XY:
209
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00657
AC:
273
AN:
41528
American (AMR)
AF:
0.00557
AC:
85
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
68004
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000947
Hom.:
0
Bravo
AF:
0.00316
ESP6500AA
AF:
0.00613
AC:
27
ESP6500EA
AF:
0.000815
AC:
7
ExAC
AF:
0.00105
AC:
127

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TICAM1: BP4, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Herpes simplex encephalitis, susceptibility to, 4 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.0050
DANN
Benign
0.80
DEOGEN2
Benign
0.085
T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.39
T;T
M_CAP
Benign
0.0074
T
MetaRNN
Benign
0.0038
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.41
N;.
PhyloP100
-3.1
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.020
N;.
REVEL
Benign
0.042
Sift
Benign
0.73
T;.
Sift4G
Benign
0.82
T;T
Polyphen
0.017
B;.
Vest4
0.086
MVP
0.22
MPC
0.22
ClinPred
0.0025
T
GERP RS
-5.1
Varity_R
0.021
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151272128; hg19: chr19-4817657; COSMIC: COSV99941356; API